🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsHow far away are we really from an oral option

How far away are we really from an oral option

SaraMom3 Wed, May 6, 2026 at 5:57 AM 10 replies 473 viewsPage 1 of 2
SaraMom3
Member
456
2,345
Aug 2024
Ohio
May 6, 2026 at 5:57 AM#1

I switched from injectable to oral semaglutide for travel reasons and the fasting window is proving harder to hold than the injection ever was.

The narrow version of the question is whether the fasting requirement is as strict in practice as the label implies, and what people actually see when they get it wrong.

If the honest answer is that nobody knows, that is a useful answer and I would rather have it.

28 23BethLabQueen, ChrisMacros, KetoKyle and 25 others
Reply Quote Save Share Report
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
May 6, 2026 at 6:21 AM#2

Answering the narrow version, because the broad one does not have a single answer. Orforglipron is the more interesting oral story because it is not a peptide at all. Being a small molecule it does not need SNAC, does not need the fasting window, and has oral bioavailability in the tens of percent rather than about one.

Last edited: May 6, 2026 at 7:21 AM
27 22mike_nyc, VendorMark, COA_Karl and 24 others
Reply Quote Save Share Report
BethLabQueen
Senior Member
1,234
5,678
May 2024
Virginia
Online
May 6, 2026 at 6:45 AM#3
DataDave said:
Orforglipron is the more interesting oral story because it is not a peptide at all.

Agreeing with DataDave, and the qualification matters more than the agreement. The absorption variability is real, but it partly averages out over weeks — the steady-state trough is less erratic than any single day would suggest. Where it bites is in the first fortnight, when people conclude the tablet does nothing.

26 21lori_vegas, Dr.PulmRoch, maya_sedona and 23 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
DeniseRN_TPA
Member
345
1,567
Aug 2024
Tampa, FL
May 6, 2026 at 7:09 AM#4
SaraMom3 said:
I switched from injectable to oral semaglutide for travel reasons and the fasting window is proving harder to hold than the injection ever was.

This matches mine closely enough to be worth saying so. The OASIS programme put 50mg oral in the same territory as 2.4mg injectable — around 15% mean weight loss — but it needed a dose 20 times larger to get there because almost none of the tablet is absorbed. The dose numbers are not comparable across routes and quoting them side by side confuses people.

Last edited: May 6, 2026 at 10:09 AM
25 20LindaRN_retired, tommy_boulder, hyun_seoul and 22 others
Reply Quote Save Share Report
NurseAsh_DET
Member
356
1,567
Sep 2024
Detroit, MI
May 6, 2026 at 9:18 AM#5

Adding the clinical framing, because it changes how the question reads. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

Last edited: May 6, 2026 at 3:18 PM
24 19emily_PDX, Dr.SleepRoch, laura_annarbor and 21 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register